Works matching IS 0195668X AND DT 2021 AND VI 42 AND IP 13
Results: 19
Common modulators of Brugada syndrome phenotype do not affect SCN5A prognostic value.
- Published in:
- European Heart Journal, 2021, v. 42, n. 13, p. 1273, doi. 10.1093/eurheartj/ehab071
- By:
- Publication type:
- Article
Different genotypes of Brugada syndrome may present different clinical phenotypes: electrophysiology from bench to bedside.
- Published in:
- European Heart Journal, 2021, v. 42, n. 13, p. 1270, doi. 10.1093/eurheartj/ehab070
- By:
- Publication type:
- Article
Glucocorticoids in patients with immune-mediated inflammatory diseases: a neglected cardiovascular risk factor.
- Published in:
- European Heart Journal, 2021, v. 42, n. 13, p. 1197, doi. 10.1093/eurheartj/ehab067
- By:
- Publication type:
- Article
Quality of life in EMPEROR-Reduced: emphasizing what is important to patients while identifying strategies to support more patient-centred care.
- Published in:
- 2021
- By:
- Publication type:
- Editorial
Corrigendum to: Gone with wind: a novel biodegradable occluder for percutaneous closure of patent foramen ovale.
- Published in:
- 2021
- Publication type:
- Correction Notice
The Dapagliflozin and Prevention of Adverse outcomes in Heart Failure trial (DAPA-HF) in context.
- Published in:
- European Heart Journal, 2021, v. 42, n. 13, p. 1199, doi. 10.1093/eurheartj/ehz916
- By:
- Publication type:
- Article
Challenges in heart failure: quality of life, chronic kidney disease, and secondary mitral regurgitation.
- Published in:
- European Heart Journal, 2021, v. 42, n. 13, p. 1185, doi. 10.1093/eurheartj/ehab154
- By:
- Publication type:
- Article
Effects of dapagliflozin on mortality in patients with chronic kidney disease: a pre-specified analysis from the DAPA-CKD randomized controlled trial.
- Published in:
- European Heart Journal, 2021, v. 42, n. 13, p. 1216, doi. 10.1093/eurheartj/ehab094
- By:
- Publication type:
- Article
Dapagliflozin, advanced chronic kidney disease, and mortality: new insights from the DAPA-CKD trial.
- Published in:
- 2021
- By:
- Publication type:
- Editorial
The management of secondary mitral regurgitation in patients with heart failure: a joint position statement from the Heart Failure Association (HFA), European Association of Cardiovascular Imaging (EACVI), European Heart Rhythm Association (EHRA), and European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC
- Published in:
- European Heart Journal, 2021, v. 42, n. 13, p. 1254, doi. 10.1093/eurheartj/ehab086
- By:
- Publication type:
- Article
Cardiac angiosarcoma detected using <sup>68</sup>Ga-fibroblast activation protein inhibitor positron emission tomography/magnetic resonance.
- Published in:
- 2021
- By:
- Publication type:
- Case Study
Thrombus in giant right atrial appendage aneurysm.
- Published in:
- 2021
- By:
- Publication type:
- Case Study
Empagliflozin and health-related quality of life outcomes in patients with heart failure with reduced ejection fraction: the EMPEROR-Reduced trial.
- Published in:
- European Heart Journal, 2021, v. 42, n. 13, p. 1203, doi. 10.1093/eurheartj/ehaa1007
- By:
- Publication type:
- Article
The Rajaie Cardiovascular Medical and Research Centre.
- Published in:
- European Heart Journal, 2021, v. 42, n. 13, p. 1190, doi. 10.1093/eurheartj/ehaa492
- By:
- Publication type:
- Article
Development and current status of Interventional cardiology in Sudan.
- Published in:
- European Heart Journal, 2021, v. 42, n. 13, p. 1190, doi. 10.1093/eurheartj/ehaa1056
- By:
- Publication type:
- Article
The cardiovascular–dialysis nexus: the transition to dialysis is a treacherous time for the heart.
- Published in:
- European Heart Journal, 2021, v. 42, n. 13, p. 1244, doi. 10.1093/eurheartj/ehaa1049
- By:
- Publication type:
- Article
The Year in Cardiovascular Medicine 2020: Coronary Prevention.
- Published in:
- European Heart Journal, 2021, v. 42, n. 13, p. 1192, doi. 10.1093/eurheartj/ehaa1023
- By:
- Publication type:
- Article
Arrhythmogenic right ventricular cardiomyopathy and sports activity: from molecular pathways in diseased hearts to new insights into the athletic heart mimicry.
- Published in:
- European Heart Journal, 2021, v. 42, n. 13, p. 1231, doi. 10.1093/eurheartj/ehaa821
- By:
- Publication type:
- Article
Corrigendum to: How to Diagnose Heart Failure with Preserved Ejection Fraction - The HFA-PEFF-SCORE An updated Consensus Statement of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC).
- Published in:
- 2021
- Publication type:
- Correction Notice